The Chiral Potential of Phenanthriplatin and Its Influence on Guanine Binding
The monofunctional platinum complex cis-[Pt(NH[subscript 3])[subscript 2]Cl(Am)][superscript +], also known as phenanthriplatin, where Am is the N-heterocyclic base phenanthridine, has promising anticancer activity. Unlike bifunctional compounds such as cisplatin, phenanthriplatin can form only one...
Main Authors: | Lippard, Stephen J. (Contributor), Johnstone, Timothy (Contributor) |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Chemistry (Contributor) |
Format: | Article |
Language: | English |
Published: |
American Chemical Society (ACS),
2015-02-24T16:05:45Z.
|
Subjects: | |
Online Access: | Get fulltext |
Similar Items
-
Nucleotide Binding Preference of the Monofunctional Platinum Anticancer-Agent Phenanthriplatin
by: Riddell, Imogen Anne, et al.
Published: (2016) -
Understanding and Improving Platinum Anticancer Drugs - Phenanthriplatin
by: Johnstone, Timothy, et al.
Published: (2015) -
DNA Intercalation Facilitates Efficient DNA-Targeted Covalent Binding of Phenanthriplatin
by: Zhou, Wen, et al.
Published: (2020) -
Structural and mechanistic studies of polymerase η bypass of phenanthriplatin DNA damage
by: Gregory, Mark T., et al.
Published: (2015) -
Phenanthriplatin, a monofunctional DNA-binding platinum anticancer drug candidate with unusual potency and cellular activity profile
by: Park, Ga Young, et al.
Published: (2013)